Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Editorial for the special Issue "Jörg Steinbach".

Constantin Mamat1

  • 1Institut für Radiopharmazeutische Krebsforschung, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

Journal of Labelled Compounds & Radiopharmaceuticals
|May 30, 2019
PubMed
Summary

This special issue honors Jörg Steinbach, a pioneer in radiopharmaceutical chemistry and cancer research. His retirement marks the end of an era in innovative radiopharmaceutical development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Twins: Exploring the Radiohybrid Concept with Iodine-123 and Lanthanum-133 for PSMA-Targeted SPECT and PET Imaging.

Journal of medicinal chemistry·2026
Same author

Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based Chelators.

Inorganic chemistry·2025
Same author

It's a match: use of the radionuclide theranostic pair <sup>133</sup>La/<sup>225</sup>Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

EJNMMI radiopharmacy and chemistry·2025
Same author

Preparation of Macrobicyclic Cryptands for Radiometal Complexation: Preparation of Macropa-Based Cryptands for Efficient Complexation of Radiometals.

Journal of labelled compounds & radiopharmaceuticals·2025
Same author

Enhancing the radionuclide theranostic concept through the radiohybrid approach.

RSC medicinal chemistry·2024
Same author

Alpha-Emitting Radionuclides: Current Status and Future Perspectives.

Pharmaceuticals (Basel, Switzerland)·2024

Area of Science:

  • Radiopharmaceutical Chemistry
  • Bioinorganic Chemistry
  • Cancer Research

Background:

  • Commemorates the scientific contributions of Jörg Steinbach.
  • Highlights his roles as Director of the Institute of Radiopharmaceutical Cancer Research at HZDR and Professor at TU Dresden.
  • Notes his retirement coinciding with legal changes and the inauguration of a new research center.

Discussion:

  • Celebrates Professor Steinbach's legacy in advancing radiopharmaceutical science.
  • Underscores the importance of his leadership in cancer research.
  • Recognizes the transition in leadership at the Institute of Radiopharmaceutical Cancer Research.

Key Insights:

  • Professor Steinbach's work has significantly impacted the field of radiopharmaceuticals.

Related Experiment Videos

  • His research has contributed to advancements in cancer diagnostics and therapeutics.
  • The establishment of the new Centre for Radiopharmaceutical Tumor Research signifies continued progress.

    • Outlook:

    • The special issue serves as a tribute to Professor Steinbach's enduring influence.
    • It anticipates future innovations in radiopharmaceutical cancer research.
    • It marks a new chapter for the Institute and the broader field.